Alder Biopharmaceuticals, Inc. financial reports, Alder Biopharmaceuticals, Inc. annual revenue in 2024. When does Alder Biopharmaceuticals, Inc. report revenue?
Alder Biopharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue Alder Biopharmaceuticals, Inc. is now 0 $. Information about net revenue is taken from open sources. Alder Biopharmaceuticals, Inc. net income is now -117 934 000 $. The dynamics of Alder Biopharmaceuticals, Inc. net income fell by -37 845 000 $ for the last reporting period. The financial graph of Alder Biopharmaceuticals, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. The financial report on the chart of Alder Biopharmaceuticals, Inc. allows you to clearly see the dynamics of fixed assets. A graph of the value of all Alder Biopharmaceuticals, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019
0 $
-
-117 934 000 $
-
31/12/2018
0 $
-100 % ↓
-80 089 000 $
-
30/09/2018
0 $
-
-60 920 000 $
-
30/06/2018
0 $
-100 % ↓
-68 389 000 $
-
31/03/2018
0 $
-
-87 031 000 $
-
31/12/2017
936 000 $
-
-54 357 000 $
-
30/09/2017
0 $
-
-59 565 000 $
-
30/06/2017
683 000 $
-
-74 629 000 $
-
Show:
to
Alder Biopharmaceuticals, Inc. financial report charts
Dates of Alder Biopharmaceuticals, Inc. finance reports: 30/06/2017, 31/12/2018, 31/03/2019. The dates of the financial statements are determined by the accounting rules. The latest financial report of Alder Biopharmaceuticals, Inc. is available online for such a date - 31/03/2019. Gross profit Alder Biopharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Alder Biopharmaceuticals, Inc. is -47 072 000 $
Alder Biopharmaceuticals, Inc. quarterly report dates
Cost of revenue Alder Biopharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Alder Biopharmaceuticals, Inc. is 47 072 000 $ Operating income Alder Biopharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Alder Biopharmaceuticals, Inc. is -114 087 000 $ Net income Alder Biopharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Alder Biopharmaceuticals, Inc. is -117 934 000 $
Current assets Alder Biopharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Alder Biopharmaceuticals, Inc. is 502 314 000 $ Total assets Alder Biopharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Alder Biopharmaceuticals, Inc. is 513 168 000 $ Current cash Alder Biopharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Alder Biopharmaceuticals, Inc. is 126 105 000 $
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-47 072 000 $
-69 338 000 $
-28 769 000 $
-32 403 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
47 072 000 $
69 338 000 $
28 769 000 $
32 403 000 $
-
936 000 $
-
683 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
936 000 $
-
683 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
936 000 $
-
683 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-114 087 000 $
-102 422 000 $
-58 478 000 $
-64 972 000 $
-85 710 000 $
-55 086 000 $
-60 424 000 $
-74 824 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-117 934 000 $
-80 089 000 $
-60 920 000 $
-68 389 000 $
-87 031 000 $
-54 357 000 $
-59 565 000 $
-74 629 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
22 517 000 $
20 111 000 $
19 024 000 $
20 415 000 $
74 048 000 $
44 749 000 $
52 188 000 $
65 276 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
114 087 000 $
102 422 000 $
58 478 000 $
64 972 000 $
85 710 000 $
55 086 000 $
60 424 000 $
74 824 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
502 314 000 $
419 809 000 $
466 550 000 $
321 205 000 $
340 742 000 $
287 254 000 $
349 411 000 $
246 638 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
513 168 000 $
426 239 000 $
496 753 000 $
548 350 000 $
599 413 000 $
303 136 000 $
366 314 000 $
253 968 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
126 105 000 $
87 865 000 $
94 410 000 $
115 754 000 $
211 956 000 $
86 896 000 $
97 334 000 $
127 789 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
60 260 000 $
28 236 000 $
30 416 000 $
29 537 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
330 961 000 $
276 240 000 $
330 885 000 $
224 481 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
252 360 000 $
212 508 000 $
211 626 000 $
207 589 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
49.18 %
49.86 %
42.60 %
37.86 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
157 053 000 $
109 976 000 $
184 032 000 $
239 666 000 $
302 398 000 $
279 275 000 $
327 170 000 $
219 421 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-74 576 000 $
-72 850 000 $
-51 474 000 $
-52 431 000 $
-74 095 000 $
-55 526 000 $
-44 837 000 $
-64 855 000 $
Last revenue report of Alder Biopharmaceuticals, Inc. was 31/03/2019. According to last financial report total revenue in Alder Biopharmaceuticals, Inc. was 0 US dollar and changed by -100% since last year. Net income in Alder Biopharmaceuticals, Inc. was -117 934 000 $ in last quartal, net income changes to 0%.
Current debt Alder Biopharmaceuticals, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Alder Biopharmaceuticals, Inc. is 60 260 000 $ Total debt Alder Biopharmaceuticals, Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Alder Biopharmaceuticals, Inc. is 252 360 000 $ Cash flow Alder Biopharmaceuticals, Inc. is the net amount of cash and cash-equivalents being transferred into and out of a business. Cash flow Alder Biopharmaceuticals, Inc. is -74 576 000 $
Alder Biopharmaceuticals, Inc. stocks data
ALDR stock price
Alder Biopharmaceuticals, Inc. stock price today, ALDR stock quote.
